Changing levels of measles antibody titers in women and children in the United States: Impact on response to vaccination

Pediatrics

Volumn 97, Issue 1, 1996, Pages 53-58

  Markowitz, Lauri E ^a   Albrecht, Paul ^b   Rhodes, Philip ^a   Demonteverde, Ruth ^c   Swint, Emmett ^a   Maes, Edmond F ^a   Powell, Clydette ^c   Patriarca, Peter A ^a   Rubenstein, Benjamin ^d   Dupee, Randall ^d   Deutsche, Mary ^d   Marcy, S Michael ^d  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

age; maternal antibody; measles; measles vaccine; race and ethnicity

Indexed keywords

MATERNAL ANTIBODY; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

ADULT; AGE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PRIORITY JOURNAL; SERUM; UNITED STATES;

ADULT; AGE FACTORS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; COHORT STUDIES; FEMALE; HUMANS; IMMUNITY, ACTIVE; INFANT; MALE; MATERNAL AGE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MIDDLE AGED; RESIDENCE CHARACTERISTICS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 13344261971     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Orenstein WA, Markowitz LE, Preblud SR, Hinman AR, Tomasi A, Bart KJ Appropriate age for measles vaccination in the United States. Dev Biol Stand. 1986,65.13-21
2. Halsey NA The optimal age for administering measles vaccine in developing countries. In: Halsey NA, De Quadros CA, eds Recent Advances in Immunization. Washington, DC: Pan American Health Organization; 1983:4-13
3. Centers for Disease Control and Prevention. Measles prevention recommendations of the Immunization Practices Advisory Committee. MMWR. 1989;38(S-9):1-18
4. Black FL Measles active and passive immunity in a worldwide perspective. Prog Med Virol. 1989;36:1-33
5. Sato H, Albrecht P, Reynolds DW, Stagnio S, Ennis FA. Transfer of measles mumps and rubella antibodies from mother to infant. Its effect on measles, mumps and rubella immunization. Am J Dis Child 1979; 133:1240-1243
6. Albrecht P, Ennis FA, Saltzman EJ, Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr. 1977;91:715-718
7. Halsey NA, Boulos R, Mode F, et al. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, nutrition, and concurrent illness. N Engl J Med. 1985;:313:544-549
8. Krugman S, Giles GP, Friedman H, Stone S. Studies on immunity to measles. J Pediatr 1965;66:471-488
9. Lennon JL, Black FL. Maternally derived measles immunity in era of vaccine-protected mothers. J Pediatr. 1986;108:671-676
10. Pabst HF, Spady DW, Marusyk RG, et al. Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J. 1992,11: 525-529
11. Gindler JS, Atkinson WL, Markowitz LE, Hutchins SS. Epidemiology of measles in the United States in 1989 and 1990. Pediatr Infect Dis J. 1992; 11:841-846
12. Markowitz LE, Demonteverde R, Albrecht P, et al Serologic response to Edmonston-Zagreb and Moraten measles vaccines, United States. Presented at the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy; October 11-14, 1992; Anaheim, CA
13. Albrecht P, Herrmann K, Burns GR. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods. 1981; 3:251-260
14. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990;162:1036-1042
15. SAS Institute Inc. SAS/STAT User's Guide Version 6, 4th ed. Cary, NC. SAS Institute Inc; 1989
16. Wilkins J, Wehrle P, Portnoy B. Live, further attenuated rubeola vaccine. Am J Dis Child. 1972;123.190-192
17. Yeager AS, Harvey B, Crosson FJ Jr, Davis JH, Ross LA, Halonen PE. Need for measles revaccination in adolescents: correlation with birth date prior to 1972. J Pediatr. 1983;102:191-195
18. Papania MJ, Lee S, Atkinson W, Markowitz LE, Finelli L, Spitalny K. Risk factors for measles in exposed children <16 months old, New Jersey. Presented at the Epidemic Intelligence Service 41st Annual Conference; April 6-10, 1992; Atlanta, GA
19. Centers for Disease Control and Prevention. Measles vaccination levels among selected groups of preschool-aged children - United States. MMWR. 1991;40:36-39
20. Black FL, Berman LL, Borgono J, et al. Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody Am J Epidemiol. 1986;124:442-452
21. Neiburg P, Dibley MJ. Risk factors for fatal measles infection. Int J Epidemiol 1986;15.309-311
22. Aaby P. Malnutrition and overcrowding/intensive exposure in severe measles infection: review of community studies. Rev Infect Dis. 1988,10: 478-491
23. Fernandez de Castro J. Measles in Mexico. Rev Infect Dis. 1983;5.422-426
24. Bromberg K, Shah B, Clark-Golden M. Maternal immunity to measles and infant immunity at less than twelve months of age relative to maternal place of birth J Pediatr. 1994;125:579-581
25. Aaby P, Samb B, Simondon F, et al. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal. Am J Epidemiol. 1993;138.746-755
26. King G, Markowitz L, Burns S, Health J, Nordin J, Bellini W A comparison of seroconversion rates at 9, 12 or 15 months of age Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, October 4-7, 1994; Orlando, FL
27. Centers for Disease Control and Prevention General recommendations on immunization. Recommendations of the advisory committee on immunization practices (ACIP). MMWR. 1994,43(RR-1):1-38